日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Fadraciclib, a CDK2/CDK9 inhibitor, shows efficacy in biliary tract cancer and synergistic potential with olaparib and JQ1 based on MCL1 expression

法德拉西利（Fadraciclib）是一种 CDK2/CDK9 抑制剂，在胆道癌中显示出疗效，并且基于 MCL1 表达，与奥拉帕尼（olaparib）和 JQ1 具有协同作用的潜力。

期刊:Cell Communication and Signaling
影响因子:8.9
doi:10.1186/s12964-025-02521-4
Kim, Jae-Min; Nam, Ah-Rong; Oh, Kyoung-Seok; Bang, Ju-Hee; Jeong, Yoojin; Choo, Sea Young; Kim, Hyo Jung; Lee, Su In; Yoon, Jeesun; Kim, Tae-Yong; Oh, Do-Youn
肿瘤
CDK9
肿瘤免疫
胆管癌
MCL1
CDK2
发表日期：2025
文献求助 收藏

Therapeutic potential of BOLD-100, a GRP78 inhibitor, enhanced by ATR inhibition in pancreatic ductal adenocarcinoma.

BOLD-100（一种 GRP78 抑制剂）在胰腺导管腺癌中的治疗潜力可通过 ATR 抑制而增强

期刊:Cell Communication and Signaling
影响因子:8.9
doi:10.1186/s12964-025-02242-8
Lee Su In, Nam Ah-Rong, Oh Kyoung-Seok, Kim Jae-Min, Bang Ju-Hee, Jeong Yoojin, Choo Sea Young, Kim Hyo Jung, Yoon Jeesun, Kim Tae-Yong, Oh Do-Youn
肿瘤
发表日期：2025
文献求助 收藏

Prognostic Value of Serum Soluble Programmed Death-Ligand 1 and Dynamics During Chemotherapy in Advanced Gastric Cancer Patients

血清可溶性程序性死亡配体1的预后价值及其在晚期胃癌患者化疗期间的动态变化

期刊:Cancer Research and Treatment
影响因子:3.8
doi:10.4143/crt.2020.497
Park, Woochan; Bang, Ju-Hee; Nam, Ah-Rong; Jin, Mei Hua; Seo, Hyerim; Kim, Jae-Min; Oh, Kyoung Seok; Kim, Tae-Yong; Oh, Do-Youn
胃癌
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

Prognostic implications of soluble programmed death-ligand 1 and its dynamics during chemotherapy in unresectable pancreatic cancer

可溶性程序性死亡配体1及其在不可切除胰腺癌化疗期间动态变化的预后意义

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-019-47330-1
Park, Hyunkyung; Bang, Ju-Hee; Nam, Ah-Rong; Eun Park, Ji; Hua Jin, Mei; Bang, Yung-Jue; Oh, Do-Youn
胰腺癌
肿瘤
肿瘤免疫
发表日期：2019
文献求助 收藏

Dynamics of Soluble Programmed Death-Ligand 1 (sPDL1) during Chemotherapy and Its Prognostic Implications in Cancer Patients: Biomarker Development in Immuno-oncology

化疗期间可溶性程序性死亡配体1 (sPDL1) 的动态变化及其在癌症患者中的预后意义：免疫肿瘤学中的生物标志物开发

期刊:Cancer Research and Treatment
影响因子:3.8
doi:10.4143/crt.2018.311
Ha, Hyerim; Bang, Ju-Hee; Nam, Ah-Rong; Park, Ji-Eun; Jin, Mei Hua; Bang, Yung-Jue; Oh, Do-Youn
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2019
文献求助 收藏

Soluble programmed death-ligand 1 (sPDL1) and neutrophil-to-lymphocyte ratio (NLR) predicts survival in advanced biliary tract cancer patients treated with palliative chemotherapy

可溶性程序性死亡配体1 (sPDL1) 和中性粒细胞与淋巴细胞比值 (NLR) 可预测接受姑息化疗的晚期胆道癌患者的生存期

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.12810
Ha, Hyerim; Nam, Ah-Rong; Bang, Ju-Hee; Park, Ji-Eun; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Oh, Do-Youn
肿瘤
中性粒细胞
肿瘤免疫
粒细胞
胆管癌
细胞生物学
发表日期：2016
文献求助 收藏